Skeletal muscle mass loss and dose‐limiting toxicities in metastatic colorectal cancer patients

Skeletal muscle mass loss and dose‐limiting toxicities in metastatic colorectal cancer patients

Abstract Background Increasing evidence suggests that severe skeletal muscle index (SMI) loss (sarcopenia) is associated with poor overall survival in metastatic colorectal cancer patients, but its mechanisms are unknown. We recently found, using data of the randomized phase 3 CAIRO3 study, that SMI...

Full description

Bibliographic Details
Main Authors: Sophie Kurk, Petra Peeters, Rebecca Stellato, B. Dorresteijn, Pim deJong, Marion Jourdan, Geert‐Jan Creemers, Frans Erdkamp, Felix deJongh, Peter Kint, Lieke Simkens, Bea Tanis, Manuel Tjin‐A‐Ton, Ankie Van Der Velden, Cornelis Punt, Miriam Koopman, Anne May
Format: Article
Language:English
Published: Wiley 2019-08-01
Series:Journal of Cachexia, Sarcopenia and Muscle
Subjects:
Body composition
Metastatic colorectal cancer
Dose‐limiting toxicity
Chemotherapy
Skeletal muscle mass
Sarcopenia
Online Access:https://doi.org/10.1002/jcsm.12436

Internet

https://doi.org/10.1002/jcsm.12436

Similar Items